SANGAMO THERAPEUTICS, INC.
SGMO · NASDAQ
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering.
Market Data
Price
$0.41
+0.00 (+0.90%)
Market Cap$152M
P/E Ratio—
EPS$—
52W High$1.06
52W Low$0.35
Beta1.39
Data from Finnhub · Updated Mar 11, 2026